Br J Ophthalmol 1998;82:67-71 ( January )
Dissociated effects of botulinum toxin chemodenervation on ocular
deviation and saccade dynamics in chronic lateral rectus palsy
J F Acheson,a
C R Bentley,a b
J Shallo-Hoffmann,b
M A Grestyb
a Department of Neuro-Ophthalmology, National Hospital
for Neurology and Neurosurgery, London, b MRC Human Movement and Balance Unit, National Hospital
for Neurology and Neurosurgery, London
Correspondence to: Mr J F Acheson, Department of Neuro-Ophthalmology, National
Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG.
Accepted for publication 13 August 1997
AIM
Changes in saccade velocity/amplitude
characteristics (main sequence) and attenuation of distance esotropia
in response to botulinum toxin (BTX-A) chemodenervation of the
antagonist medial rectus were studied in a group of nine patients with
chronic lateral rectus palsy.
METHODS
Serial measurements of ocular deviation
and infrared oculograms of saccadic eye movements to targets at
5°-20° of lateral gaze were made before injection and at 2, 4, 8, 16, and 20 weeks after injection.
RESULTS
At 2 weeks after injection, the ocular
deviation changed by a mean of 34.5 prism dioptres and the 5° and
10° adduction saccades were significantly slowed (p<0.02 Wilcoxon
signed rank test). By the second examination, however, the adducting
saccade peak velocity had returned to normal while the mean ocular
deviation remained significantly changed (p=0.01 Wilcoxon matched
pairs). By 20 weeks the mean ocular deviation was not significantly
different from that before injection (p=0.14 matched pairs).
CONCLUSIONS
The ocular realignment caused by BTX-A
may persist after saccadic function has been restored. This may be
because toxin may have a more profound and long lasting effect on the
orbital singly innervated fibres which are active tonically at rest to
hold gaze whereas there is relative sparing of the additional motor
units recruited during fast eye movements.
Keywords:
lateral rectus palsy;
botulinum toxin;
saccades
© 1998 by British Journal of Ophthalmology